Navigation Links
EY Announces Brian Meshkin, CEO at Proove Biosciences, as EY Entrepreneur Of The Year® 2016 Orange County Semifinalist for the 2nd Year in a Row
Date:4/12/2016

Proove Biosciences, Inc., the commercial and research leader in personalized pain medicine, is pleased to announce that Brian Meshkin, CEO at Proove Biosciences, is named as a semifinalist for the EY Entrepreneur Of The Year® 2016 Orange County Region. Now celebrating its 30th year, the awards program recognizes entrepreneurs in over 145 cities and 60 countries who demonstrate excellence and extraordinary success in such areas as innovation, financial performance, and personal commitment to their businesses and communities. Brian Meshkin was selected as a semifinalist by a panel of independent judges. Finalists will be announced Monday, May 23—and winners will be announced at a formal Awards Gala on Friday, June 17. The Awards Gala, which is held at St. Regis Monarch Beach Resort in Dana Point, California, is expected to host more than 500 Founders, CEOs, and other business leaders.

“It is such a humbling honor to be selected as a semifinalist again for this prestigious award,” said Meshkin. “To be in the running for an award from an organization like EY—in a dynamic and thriving community like Orange County—reflects the commitment of the everyone at Proove to our mission of improving healthcare decisions to enhance patient care for our nation’s largest and most expensive health condition which is pain.” Regional award winners are eligible for consideration for the EY Entrepreneur Of The Year National Awards. Award winners in several national categories, as well as the overall national award winner, will be announced at the EY Entrepreneur Of The Year National Awards gala in Palm Springs, California, on November 19, 2016. The awards gala is the culminating event of the EY Strategic Growth Forum®, the nation’s most prestigious gathering of high-growth, market-leading companies.

The recognition from EY comes on the heels of Meshkin’s receipt of the 15th Annual Excellence in Entrepreneurship Award from the Orange County Business Journal last month. To learn more about Brian Meshkin’s journey as an EY Entrepreneur Of The Year semifinalist, follow Proove Biosciences on Twitter at @proovebio. To follow the latest program developments of the award program on Twitter, interact with @EY_EOYUS using #EOYOC and visit the Orange County regional website at http://www.ey.com/us/eoy/oc.

About Proove Biosciences
Our mission is to change the future of medicine. Proove represents the proof to improve healthcare decisions. We seek to realize a future when clinicians look back and wonder how they could have ever prescribed medications without knowing how a patient would respond. Physicians use Proove Biosciences testing to improve outcomes—both safety and efficacy of medical treatment. From a simple cheek swab collected in the office, Proove performs proprietary genetic tests in its CLIA-certified laboratory to identify patients at risk for misuse of prescription pain medications and evaluate their metabolism of medications. For more information, please visit http://www.proove.com or call toll free 855-PROOVE-BIO (855-776-6832).

About EY Entrepreneur Of The Year®
EY Entrepreneur Of The Year is the world’s most prestigious business award for entrepreneurs. The unique award makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 145 cities in more than 60 countries.

About EY’s Strategic Growth Markets practice
EY’s Strategic Growth Markets (SGM) practice guides leading high-growth companies. Our multidisciplinary teams of elite professionals provide perspective and advice to help our clients accelerate market leadership. SGM delivers assurance, tax, transactions and advisory services to thousands of companies spanning all industries. EY is the undisputed leader in taking companies public, advising key government agencies on the issues impacting high-growth companies and convening the experts who shape the business climate. For more information, please visit us at ey.com/us/strategicgrowthmarkets, or follow news on Twitter @EY_Growth.

About EY
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.

Read the full story at http://www.prweb.com/releases/2016/04/prweb13333455.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. Genedata Announces the Release of Genedata Bioprocess - New Workflow Platform for Biopharmaceutical Development
2. SPIE Announces 2016 Award Recipients for Achievements in Optics and Photonics
3. DELVE HEALTH Announces New Advisory Board
4. CSM Announces Promotion of Brian Swites to President
5. Rocky Mountain Biologicals Announces Water for Injection (WFI) Manufacturing Facility in West Jordan, Utah
6. Temarry Recycling Announces That Exporting Hazardous Waste Eliminates Biennial Reporting Requirement
7. Charm Sciences Announces FDA Release of 2400 Forms for Charm Peel Plate AC and EC Microbial Tests
8. CfPIE Announces New Training Course on the Regulated Medical Marijuana Business
9. Global Stem Cells Group Announces Manufacturing Phase of Progenikine™ SVF Closed System
10. TEDxASU Announces World Renowned Virology Expert, Dr. Betram Jacobs, PhD, as Speaker for First ASU TEDx Event
11. BioLineRx Announces Initiation of Phase 2 Trial for BL-8040 as Novel Stem Cell Mobilization Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 11, 2017 , ... The CRISPR-Cas9 system has ... and avoiding the use of exogenous expression plasmids. The simplicity of programming this ... gain-of-function studies. , This complement to loss-of-function studies, such as with RNAi ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM ... firm for the life sciences and healthcare industries, announces a presentation by Subbu ... , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a ...
Breaking Biology Technology:
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
Breaking Biology News(10 mins):